AIG
PRME icon

American International Group’s Prime Medicine PRME Stock Holding History

American International Group’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19,496
Closed -$136K – 2049
2024
Q1 		$136K Sell
19,496
-167
-0.8% -$1.27K ﹤0.01% 2357
2023
Q4 		$174K Sell
19,663
-80
-0.4% -$616 ﹤0.01% 2238
2023
Q3 		$188K Buy
19,743
+703
+4% +$9.13K ﹤0.01% 2163
2023
Q2 		$279K Buy
19,040
+13,953
+274% +$195K ﹤0.01% 1989
2023
Q1 		$62.6K Buy
5,087
+178
+4% +$2.9K ﹤0.01% 2649
2022
Q4 		$91.2K Buy
+4,909
New +$88.7K ﹤0.01% 2557

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

American International Group's PRME Position: Q2 2024 in Review

American International Group sold out of Prime Medicine (PRME) in Q2 2024, closing a stake of 19,496 shares — an estimated $136K sold.

American International Group first reported a position in PRME in Q4 2022 and held it in 6 quarters. The position peaked at $279K in Q2 2023. 122 funds tracked by Wall St. Rank hold PRME as of Q2 2024.

  • American International Group reported no remaining Prime Medicine position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 19,496 Prime Medicine shares in Q2 2024, an estimated $136K.
  • American International Group first reported a position in Prime Medicine in Q4 2022 and held it in 6 quarters.
  • American International Group's Prime Medicine position peaked at $279K in Q2 2023.
  • 122 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.